Department of Pancha-Karma, State Ayurvedic College, Lucknow, India.
J Altern Complement Med. 2012 Jul;18(7):719-22. doi: 10.1089/acm.2011.0351.
Ayurvedic medicines are often considered effective for treating chronic and lifestyle-related diseases only and have not been thoroughly evaluated for treating acute or terminal illnesses. A prospective evaluation of Ayurvedic intervention was proposed for a patient who had metastatic liver disease with abnormal liver functions. The reason given for this was that no other conventional therapies were feasible in this case, and the family and caregivers were not willing to opt for any other intervention.
A diagnosed patient with metastatic liver disease that included abnormal liver functions and symptomatic presentation was treated with Ayurvedic therapies and was observed for 10 days for any possible changes.
A substantial clinical and biochemical improvement was observed in this patient after 10 days of treatment. This improvement was noted to be consistent at a 1-week follow-up after the patient was discharged from the hospital.
This case offers an opportunity to reconsider whether or not the toxic potentials of heavy metals used in Ayurvedic agents outweigh the possible benefits for treating patients with well-defined, incurable clinical conditions.
阿育吠陀药物通常被认为仅对治疗慢性和与生活方式相关的疾病有效,而对于治疗急性或终末期疾病尚未进行彻底评估。针对一名患有肝功能异常的转移性肝疾病患者,提出了对阿育吠陀干预措施进行前瞻性评估的建议。提出这一建议的原因是,在这种情况下,没有其他常规疗法可行,而且家属和护理人员不愿意选择任何其他干预措施。
对一名患有转移性肝疾病的确诊患者进行了阿育吠陀疗法治疗,该患者的肝功能异常且有症状表现,对其进行了 10 天的观察,以观察任何可能的变化。
在治疗 10 天后,该患者的临床和生化情况得到了显著改善。在患者出院后一周的随访中,这种改善情况被认为是一致的。
本病例提供了一个机会,重新考虑阿育吠陀制剂中使用的重金属的毒性潜力是否超过了治疗明确、无法治愈的临床病症患者的可能益处。